Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1993Arthritis & Rheumatism

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMichael J. ElliottChildren's Hospital Central CaliforniaRMRavinder N. MainiImperial College LondonMarc FeldmannMarc FeldmannUniversity College Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elliott et al. (1993) studied this question.

synapsesocial.com/papers/6a73c5eb490419ae8169f028https://doi.org/10.1002/art.1780361206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunotherapy and other novel therapies1991 · 4 citations
  2. 2THE ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING A MULTIVARIATE ANALYSIS1981 · 137 citations
  3. 3TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?1992 · 388 citations
  4. 4Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.1989 · 258 citations
  5. 5Localization of tumor necrosis factor receptors in the synovial tissue and cartilage‐pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor α1992 · 218 citations